Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) 그림

38 동료 심사 연구의 그림

전체 Vitamin E Green Tea Extract (EGCG) Citicoline Folate Zinc Bacopa monnieri Omega-3 Fatty Acids (DHA/EPA) Alpha-Lipoic Acid Creatine Resveratrol Vitamin D L-Theanine Vitamin B12 Ginkgo biloba Lutein & Zeaxanthin Melatonin Rhodiola rosea Panax Ginseng Phosphatidylserine Taurine Curcumin Uridine Monophosphate
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 3. Pictorial representation of Cordyceps therapeutic potential in general. Table 2. Nutraceutical products from Cordyceps available on the global market.
Figure 8

Cordyceps-derived products are available globally as nutraceutical supplements. This figure combines a pictorial representation of Cordyceps' therapeutic potential with a table of commercially available nutraceutical formulations.

Cordycepin for Health and Wellbeing: A Potent Bioactive Metabolite of an Entomopathogenic …

Figure 24
Figure 24

Comprehensive drug interaction summary for vortioxetine, including effects on and by concomitant medications. Clinicians are advised to consider CYP2D6 inhibitor status when prescribing vortioxetine.

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions.

Figure 3
Figure 3

[Not Available].

Figure 4
Figure 4

[Not Available].

Figure 4 Diagram of the mechanism of GB on independent risk factors for atherosclerosis. Trimethylamine N-oxide (TMAO) levels in the blood can be utilized as a predictor of early atherosclerosis. Trimellitic anhydride (TMA) is derived from digested and ab
Figure 5

Figure 4 Diagram of the mechanism of GB on independent risk factors for atherosclerosis. Trimethylamine N-oxide (TMAO) levels in the blood can be utilized as a predictor of early atherosclerosis. …

[Not Available].

Figure 4
Figure 4

Formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity.

Figure 8
Figure 8

Formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity.

Figure 9
Figure 9

Formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity.

Figure 10
Figure 10

Formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity.

Figure 11
Figure 11

Formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity.

Figure 12
Figure 12

Formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity.

Figure 1
Figure 1

Alopecia and platelet-derived therapies.

Figure 2
Figure 2

Alopecia and platelet-derived therapies.

Figure 3 Location of the PL, AA-PRP, and saline treatment zones for Subject C. Forty grafts were placed in each box, and hair checks were conducted 14 weeks post-surgery. PL, platelet lysate; AA– PRP, autologous activated platelet rich plasma.
Figure 3

Figure 3 Location of the PL, AA-PRP, and saline treatment zones for Subject C. Forty grafts were placed in each box, and hair checks were conducted 14 weeks post-surgery. PL, …

Alopecia and platelet-derived therapies.

Figure 4
Figure 4

Alopecia and platelet-derived therapies.

Figure 5
Figure 5

Alopecia and platelet-derived therapies.

Before
Figure 6

Before

Alopecia and platelet-derived therapies.

Figure 1: Step-by-step flow diagram of preparation of platelet-rich plasma using open double-spin method
Figure 1

Figure 1: Step-by-step flow diagram of preparation of platelet-rich plasma using open double-spin method

Platelet-Rich Plasma in Androgenetic Alopecia.

Fig. 1. Regional (A) R2, (B) R2*, (C) R2′ and (D) QSM values corrected for age and volume for healthy controls (blue) and RLS patients (red). CAU: Caudate, DEN: Dentate nuclei, PAL: Pallidum, PUT: Putamen, RN: Red nuclei, SN: Substantia Nigra, STN: Subtha
Figure 3

Fig. 1. Regional (A) R2, (B) R2*, (C) R2′ and (D) QSM values corrected for age and volume for healthy controls (blue) and RLS patients (red). CAU: Caudate, DEN: Dentate …

Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging.

Fig. 2. Flow Diagram of the systematic search for MRI studies of iron in RLS.
Figure 4

Fig. 2. Flow Diagram of the systematic search for MRI studies of iron in RLS.

Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging.

Figure 5
Figure 5

Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging.

Figure 1
Figure 1

Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies …

Figure 3
Figure 3

Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies …

Figure 4
Figure 4

Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies …

2페이지 중 1페이지